AbSci has developed a proprietary engineered E. coli expression system, SoluPro™ that will allow for an easily optimizable and scalable production of soluble recombinant proteins. Our game-changing core technology allows proteins (including antibodies and enzymes) to be produced at a fraction of their current cost, without any corresponding loss in performance characteristics. In addition, use of the versatile SoluPro™ platform accelerates the R&D process by enabling rapid access to soluble protein for screening purposes. These therapeutic proteins and antibodies are used in cancer and hormone therapies, as well as autoimmune and blood disorder therapies.
Accelerator Life Science Partners is a vehicle for disciplined and efficient investment in and management of emerging biotechnology opportunities. The company identifies, evaluates, finances and manages groundbreaking emerging life sciences opportunities.
Acylin is the first biotechnology company focused on developing inhibitors of cellular acylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease and neurodegeneration.
Acquired in 2014.
Breaking drug resistance in cancer through the development of a new class of therapies that target key drivers of ongoing DNA mutation and tumor evolution.
Arzeda has the world-leading computational enzyme design technology and is changing the way people think about biocatalysis. Arzeda’s team brings more than 20 years of combined experience in the field of computational and experimental protein engineering.
Bellwether Bio is a privately-held Seattle-based startup developing novel cell-free DNA-based diagnostic technologies.
EpiThany is dedicated to the advancement of innovative therapies that can improve the lives of cancer patients. Our focus is on developing tumor vaccines that drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) responses.
We're Building Something Exciting. Check Back Soon.
Hyperion Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology.
Acquired by Horizon Pharma in March 2015.
As a fully integrated biotherapeutics company, Ikaria is positioned to help advance critical care. Leveraging a combination of highly specialized insight into human biology, clinical expertise, an intimate understanding of clinical needs and an intense level of caring allows Ikaria to achieve remarkable goals.
Acquired by Mallinckrodt in March 2015.
Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies.
Initial Public Offering (NASDAQ: JUNO) in December 2014.
Nexgenia’s smart, magnetic nano-particles significantly improve both speed and binding sensitivity for Diagnostic and Life Science applications.
Nohla Therapeutics is the world leader in development of ex vivo expanded universal donor cellular therapies, available on demand for treatment of life threatening diseases.
Phase Genomics' mission is to help scientists make breakthrough discoveries by providing the most complete, accurate, detailed genomes and metagenomes available from any technology.
Phytelligence has a portfolio of proprietary technologies to grow new and improved food crops faster and more reliably.
Resolve Therapeutics is pioneering a novel approach to the treatment of Systemic Lupus Erythematosus (SLE), a potentially life-threatening autoimmune disease that affects some 1.5 million people in the United States and over 5 million patients worldwide.
Rodeo Therapeutics is a preclinical-stage biotech company focused on first in class small molecule modulators of prostaglandin biology for enhancing tissue repair and regeneration.
Targeted Growth, Inc. (TGI) is a crop biotechnology company focused on developing products with enhanced yield and improved quality for the agriculture and energy industries.
VLST Corp. is a biotechnology company that has developed a novel and streamlined approach to speed the development of effective therapeutics for the treatment of inflammatory and autoimmune diseases. The VLST platform uses novel bioinformatics and state-of-the-art proteomics to identify viral genes whose protein products function as immunomodulatory agents.
An elemental approach to better batteries: Group14 uses its unique high performance carbon engineering abilities to create cohesive silicon-carbon nanocomposites that dramatically outperform traditional carbon coated silicons. Our carbon makes any silicon work much better and when combined with our novel, low-cost nano-silicon, Group14 delivers a value proposition better than graphite.
EnerG2’s mission is to produce engineered materials for energy storage at prices and performance levels that enable entirely new storage applications.
Acquired by BASF Venture Capital America Inc. in June 2016.
Modumetal™ is a revolutionary nanolaminated alloy that is stronger and lighter than steel and will replace conventional metals and composites in many applications, starting with military armor, and eventually in cars, planes, buildings, and other transportation and construction sectors.
Based in Bothell, Washington, Aqueduct Critical Care was founded in October of 2013 by a group of seasoned medical device entrepreneurs led by Tom Clement, President and CEO. The company was founded to develop and commercialize technology invented at the nearby University of Washington.
Developing advanced body worn sensing and computing technologies for diagnostic testing in cardiology, respiratory and other complex disease states.
Since 2007, TransformativeMed has built a reputation as a worldwide leader in Cerner EMR integration and innovation, leveraging the MPages development toolkit. Our innovative solutions have enabled more than 40 hospitals to maximize the value of their EMR investment. With Smart Health Apps from TransformativeMed, hospitals can focus on what matters most: patients, providers, and outcomes.
Uptake Medical is developing a novel, minimally invasive lung volume reduction technology for patients suffering from emphysema and other types of chronic obstructive pulmonary diseases (COPD).
Acquired by Broncus Holding Company in August 2016.
We are a leading provider of GLP/GCP compliant accelerator mass spectrometry (AMS) services to the global pharmaceutical and life science industries. Our customers use AMS services to overcome challenges they face in drug development, including assessment of pharmacokinetics, metabolism and mass balance.
nLIGHT is a leading supplier of high-power semiconductor-based lasers for microelectronics, material processing, defense and medical applications. nLIGHT develops and manufactures fiber lasers, diode-pumped solid-state lasers and direct-diode lasers.
World's first receiver that combines the extreme bandwidth of direct sampling (2GHz instantaneous Nyquist bandwidth) with unprecedented high dynamic range
WiBotic provides the most reliable wireless power and battery intelligence solutions to charge your aerial, mobile and aquatic robot systems.
SNUPI Technologies is a sensor and services company focused on home safety, security, and loss prevention. Our customers use our devices, in connection with our monitoring service, to discover and alert themselves when a hazardous event occurs in their home. SNUPI (Sensor Network Utilizing Powerline Infrastructure) technology is an ultra-low-power, general-purpose wireless sensing platform that is easily used and maintained by leveraging the existing electrical wiring as a whole home antenna.
WallyHome technology acquired by Sears Holdings Corp. in October 2015.
AnswerDash was born out of four years of scientific research at the University of Washington into how people interact with websites, both desktop and mobile. That research revealed that people are regularly confused online, and when they are, they prefer to simply select items they have questions about, rather than describing their problems in text (as required by email, live chat, forums, or searchable knowledgebases). AnswerDash's mission is to reduce site abandonment by providing selection-based answers online, right where people need them. No typing. No digging. No leaving the page. Simply click or tap to get an answer. Easy and effective.
appAttach is an online marketplace that connects PC, tablet and smartphone providers with app developers, enabling them to easily find, transact and manage preload deals.
Decide's e-commerce service finds the lowest prices for a vast range of consumer electronics and offers predictions on new model releases and future price changes.
Seattle-based C-SATS, Inc. is a venture-backed healthcare technology company on a mission to empower the nation's 16 million healthcare workers and institutions to assess and improve their performance continuously, accurately and objectively. Developed at the University of Washington, our scalable software utilizes a unique combination of distributed experts and extra-institutional reviewers to assess technical performance with accuracy equivalent to gold standards. It's Crowd-Sourced Assessment of Technical Skills...or C-SATS.
FlexMinder delivers Software as a Service (SaaS) that saves consumers time and money while reducing costs for TPAs, private health exchanges and health carriers. FlexMinder simplifies the consumer experience by aggregating an individual's healthcare information from multiple sources and automating the reimbursement process for their FSA healthcare claims.
Acquired by Jellyvision in January 2017.
Protemo provides specialized services to the wireless industry.
Shippable is a cloud platform that gives developers a seamless way to add continuous integration and deployment to GitHub projects. It takes less than a minute to set up and requires no maintenance. You sign in with your GitHub credentials, add a config file, create a job, and voila - we will run your builds and tests for every code commit. Our goal is to let you focus on coding, and leave the integrating and deploying to us.
Skytap is the leading provider of cloud-based virtual labs that deliver 100% self-service provisioning of complex IT environments without any architectural changes.